The study showed that most men who had nerves on both sides of the gland could reach orgasm.
NEW YORK (Reuters Health) – Most men who have undergone surgery for prostate cancer can still achieve orgasm if the nerves surrounding the prostate are not removed, according to a new study.
Researchers at Cornell University say that the age of man and the number of nerves he saved will play a role in his ability to peak after surgery.
The study followed 408 men who underwent a procedure to remove the prostate, known as robot-assisted endoscopic prostatectomy, between 2005 and 2007 for an average of three years. The men had an average age of 60 years and all could reach orgasm before the operation.
Seventy-four percent of men were able to save their nerves bilaterally, or on both sides. Of these men, 91 percent had no change in their ability to achieve orgasm after surgery.
About 13 percent of men suffered from their nerves on only one side. Of this group, 82 percent of men had the same access to orgasm. Another 12 percent had little or no nephropathy, with 62 percent able to achieve orgasm in the same way as before the operation.
The age of men also played a role in their ability to reach orgasm. The study, published in the February issue of BJUI, showed that orgasm rates were significantly higher in men younger than 60 who were saving their nerves on both sides. The rate of orgasm decreased between 10% and 83% among men over 60, even if their nerves had survived on both sides.
A questionnaire conducted by 156 men who managed to achieve orgasm after surgery revealed that 82 percent had high satisfaction rates. Another 10 percent said they were moderately satisfied and 7 percent reported low satisfaction. About 3 percent of the men said they suffered from a painful orgasm.
“As far as we know, this is the largest analysis of the function of orgasm in the literature of robotic protectorate and will provide valuable information to surgeons who speak with patients about the type of sexual function they can expect after surgery,” study author, Dr. Ashutosh Tiwari, director of the Prostate Cancer Institute Weill Cornell Medical College in a press release.